{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:29:08Z","timestamp":1770539348770,"version":"3.49.0"},"reference-count":20,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1111\/liv.15696","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T07:43:26Z","timestamp":1695023006000},"page":"2057-2059","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk of severe infection in patients with non\u2010alcoholic fatty liver disease: Implication on clinical management"],"prefix":"10.1111","volume":"43","author":[{"given":"Mary Yue","family":"Wang","sequence":"first","affiliation":[{"name":"Medical Data Analytics Center, Department of Medicine and Therapeutics The Chinese University of Hong Kong  Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-9410","authenticated-orcid":false,"given":"Vincent Wai\u2010Sun","family":"Wong","sequence":"additional","affiliation":[{"name":"Medical Data Analytics Center, Department of Medicine and Therapeutics The Chinese University of Hong Kong  Hong Kong"},{"name":"State Key Laboratory of Digestive Disease, Institute of Digestive Disease The Chinese University of Hong Kong  Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1819-2464","authenticated-orcid":false,"given":"Terry Cheuk\u2010Fung","family":"Yip","sequence":"additional","affiliation":[{"name":"Medical Data Analytics Center, Department of Medicine and Therapeutics The Chinese University of Hong Kong  Hong Kong"},{"name":"State Key Laboratory of Digestive Disease, Institute of Digestive Disease The Chinese University of Hong Kong  Hong Kong"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,9,18]]},"reference":[{"issue":"4","key":"e_1_2_5_2_1","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/hep.32774","article-title":"Geographical similarity and differences in the burden and genetic predisposition of NAFLD","volume":"77","author":"Yip TC","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"e_1_2_5_3_1","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne CD","year":"2015","journal-title":"J Hepatol"},{"issue":"3","key":"e_1_2_5_4_1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.mcna.2022.12.003","article-title":"Nonalcoholic fatty liver disease: a unique entity or part of the metabolic syndrome or both","volume":"107","author":"Yip TC","year":"2023","journal-title":"Med Clin North Am"},{"issue":"2","key":"e_1_2_5_5_1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hep.32633","article-title":"Age and the relative importance of liver\u2010related deaths in nonalcoholic fatty liver disease","volume":"77","author":"Lin H","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"e_1_2_5_6_1","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII\u2014renewing consensus in portal hypertension","volume":"76","author":"Franchis R","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"e_1_2_5_7_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest R","year":"2014","journal-title":"J Hepatol"},{"issue":"3","key":"e_1_2_5_8_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrgastro.2015.15","article-title":"Leaky guts: intestinal permeability and NASH","volume":"12","author":"Ray K","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"e_1_2_5_9_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.livres.2020.02.003","article-title":"The alteration of immune cells in the pathogenesis of non\u2010alcoholic fatty liver disease and non\u2010alcoholic steatohepatitis","volume":"4","author":"Dechun F","year":"2020","journal-title":"Liver Res"},{"key":"e_1_2_5_10_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103768","article-title":"Peripheral immune cells in NAFLD patients: a spyhole to disease progression","volume":"75","author":"Lin SZ","year":"2022","journal-title":"EBioMedicine"},{"issue":"11","key":"e_1_2_5_11_1","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1007\/s00125-021-05522-3","article-title":"Diabetes and the risk of hospitalisation for infection: the atherosclerosis risk in communities (ARIC) study","volume":"64","author":"Fang M","year":"2021","journal-title":"Diabetologia"},{"issue":"3","key":"e_1_2_5_12_1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s15010-021-01749-9","article-title":"Body mass index and risk of clostridioides difficile infection: a systematic review and meta\u2010analysis","volume":"50","author":"Charoenngam N","year":"2022","journal-title":"Infection"},{"issue":"2","key":"e_1_2_5_13_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/qjmed\/hcy227","article-title":"Non\u2010alcoholic fatty liver disease and 30\u2010day all\u2010cause mortality in adult patients with community\u2010acquired pneumonia","volume":"112","author":"Nseir WB","year":"2019","journal-title":"QJM"},{"issue":"3","key":"e_1_2_5_14_1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10096-019-03759-w","article-title":"Nonalcoholic fatty liver disease as a risk factor for Clostridioides difficile infection","volume":"39","author":"Papic N","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"e_1_2_5_15_1","first-page":"386","article-title":"Non\u2010alcoholic fatty liver disease is associated with recurrent urinary tract infection in premenopausal women independent of metabolic syndrome","volume":"21","author":"Nseir W","year":"2019","journal-title":"Isr Med Assoc J"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.05.013"},{"issue":"3","key":"e_1_2_5_17_1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez J","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"e_1_2_5_18_1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dsx.2020.04.004","article-title":"Diabetes in COVID\u201019: prevalence, pathophysiology, prognosis and practical considerations","volume":"14","author":"Singh AK","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"e_1_2_5_19_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar\u2010Gomez E","year":"2015","journal-title":"Gastroenterology"},{"issue":"10390","key":"e_1_2_5_20_1","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric\u2010metabolic surgery versus lifestyle intervention plus best medical care in non\u2010alcoholic steatohepatitis (BRAVES): a multicentre, open\u2010label, randomised trial","volume":"401","author":"Verrastro O","year":"2023","journal-title":"Lancet"},{"issue":"6","key":"e_1_2_5_21_1","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","article-title":"Breakthroughs in therapies for NASH and remaining challenges","volume":"76","author":"Ratziu V","year":"2022","journal-title":"J Hepatol"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/liv.15696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T07:43:41Z","timestamp":1695023021000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/liv.15696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1111\/liv.15696"],"URL":"https:\/\/doi.org\/10.1111\/liv.15696","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,18]]},"assertion":[{"value":"2023-08-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}